Cabot (CBT)
(Delayed Data from NYSE)
$110.86 USD
-0.91 (-0.81%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $110.92 +0.06 (0.05%) 7:58 PM ET
2-Buy of 5 2
A Value A Growth B Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$110.86 USD
-0.91 (-0.81%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $110.92 +0.06 (0.05%) 7:58 PM ET
2-Buy of 5 2
A Value A Growth B Momentum A VGM
Zacks News
Here's Why Cabot (CBT) is a Strong Momentum Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Cabot (CBT) is a Great Momentum Stock: Should You Buy?
by Zacks Equity Research
Does Cabot (CBT) have what it takes to be a top stock pick for momentum investors? Let's find out.
Why Cabot (CBT) is a Top Value Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Is Cabot (CBT) Outperforming Other Basic Materials Stocks This Year?
by Zacks Equity Research
Here is how Cabot (CBT) and Hawkins (HWKN) have performed compared to their sector so far this year.
Should Value Investors Buy Cabot (CBT) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Cabot's Stock Rises 16% in Three Months: What's Driving the Rally?
by Zacks Equity Research
CBT's upside is fueled by strong segment performance, consistent earnings beats and an upbeat fiscal 2024 outlook.
Zacks.com featured highlights include NetApp, Cabot, Leidos, Charles River Associates and HCA Healthcare
by Zacks Equity Research
NetApp, Cabot, Leidos, Charles River Associates and HCA Healthcare are part of the Zacks Screen of the Week article.
5 Dividend Growth Stocks Likely to Outperform Amid Low Rates
by Sweta Killa
NetApp, Cabot, Leidos Holdings, Charles River and HCA Healthcare could be compelling picks amid a low rate scenario.
Cabot Chosen for $50M Award Negotiation to Aid Battery Supply Chain
by Zacks Equity Research
The new manufacturing operation of CBT will boost the domestic supply chain for crucial battery ingredients, lowering dependency on foreign imports.
Cabot's Shares Reach Fresh 52-Week High: What's Driving It?
by Zacks Equity Research
CBT's shares hit a 52-week high, fueled by strong segment growth, higher earnings and an upbeat outlook on robust market demand.
Cabot Corporation (CBT) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Cabot (CBT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Are Basic Materials Stocks Lagging Cabot (CBT) This Year?
by Zacks Equity Research
Here is how Cabot (CBT) and Vista Gold (VGZ) have performed compared to their sector so far this year.
3 Reasons Why Growth Investors Shouldn't Overlook Cabot (CBT)
by Zacks Equity Research
Cabot (CBT) possesses solid growth attributes, which could help it handily outperform the market.
Are Investors Undervaluing Cabot (CBT) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks.com featured highlights include Vertiv, Charles River Associates, Cabot, Leidos and HCA Healthcare
by Zacks Equity Research
Vertiv, Charles River Associates, Cabot, Leidos and HCA Healthcare are part of the Zacks Screen of the Week article.
Cabot's Shares Rise 18% in Six Months: What's Driving the Stock?
by Zacks Equity Research
CBT's upside is fueled by strong segment performance, consistent earnings beat and an upbeat fiscal 2024 outlook.
5 Dividend Growth Stocks to Buy in Historically Weak September
by Sweta Killa
Vertiv Holdings, Charles River, Cabot, Leidos Holdings and HCA Healthcare could be solid choices for a historically weak September.
Cabot (CBT) Down 0% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Cabot (CBT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Linde Announces $2B Clean Hydrogen Investment in Canada's Alberta
by Zacks Equity Research
The new complex, spearheaded by LIN, will utilize the autothermal reforming technology, along with its proprietary HISORP carbon capture system, to produce clean hydrogen.
Here's Why You Should Add Cabot Stock to Your Portfolio Now
by Zacks Equity Research
CBT is poised for strong growth, driven by robust performance in its business segments on healthy demand.
Why Cabot (CBT) is a Top Momentum Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Is Cabot (CBT) Stock Outpacing Its Basic Materials Peers This Year?
by Zacks Equity Research
Here is how Cabot (CBT) and Element Solutions (ESI) have performed compared to their sector so far this year.
Is Cabot (CBT) a Solid Growth Stock? 3 Reasons to Think "Yes"
by Zacks Equity Research
Cabot (CBT) could produce exceptional returns because of its solid growth attributes.
Is Cabot (CBT) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.